angiotensin
convert
receptor
mediat
entri
cell
three
strain
coronaviru
sarscov
receptor
ubiquit
wide
express
heart
vessel
gut
lung
particularli
type
pneumocyt
macrophag
kidney
testi
brain
mostli
bound
cell
membran
scarc
present
circul
solubl
form
import
salutari
function
membranebound
solubl
degrad
angiotensin
ii
angiotensin
consequ
receptor
limit
sever
detriment
effect
result
bind
angiotensin
ii
receptor
includ
vasoconstrict
enhanc
inflamm
thrombosi
increas
gener
angiotensin
also
trigger
counterregulatori
protect
effect
bind
gprotein
coupl
ma
receptor
unfortun
entri
cell
membran
fusion
markedli
downregul
receptor
loss
catalyt
effect
receptor
extern
site
membran
increas
pulmonari
inflamm
coagul
report
unwant
effect
enhanc
unoppos
angiotensin
ii
effect
via
receptor
axi
clinic
report
patient
infect
show
sever
featur
associ
infect
sever
diseas
ie
older
age
hypertens
diabet
cardiovascular
diseas
share
variabl
degre
defici
suggest
downregul
induc
viral
invas
may
especi
detriment
peopl
baselin
defici
associ
condit
addit
defici
viral
invas
might
amplifi
dysregul
advers
receptor
axi
protect
receptor
axi
lung
dysregul
would
favor
progress
inflammatori
thrombot
process
trigger
local
angiotensin
ii
hyperact
unoppos
angiotensin
set
recombin
angiotensin
angiotensin
ii
type
receptor
blocker
could
promis
therapeut
approach
patient
infect
entri
cell
mediat
effici
bind
spike
viral
protein
amino
acid
long
protein
belong
viral
envelop
protrud
outward
corona
like
appear
angiotensin
convert
enzym
receptor
receptor
discov
two
independ
group
year
transmembran
type
glycoprotein
monocarboxypeptidas
compos
amino
acid
use
singl
extracellular
catalyt
domain
remov
one
singl
amino
acid
octapeptid
angiotensin
ii
gener
angiotensin
receptor
also
convert
angiotensin
angiotensin
turn
convert
angiotensin
ace
neprilisin
figur
catalyt
effici
time
higher
angiotensin
ii
angiotensin
show
structur
ident
ace
although
aceinhibitor
block
differ
conform
structur
catalyt
site
mediat
cell
entri
three
strain
coronaviru
sarscov
notabl
sarscov
share
ident
amino
acid
sequenc
therebi
explain
propens
virus
bind
structur
variat
human
identifi
character
lower
bind
affin
spike
viral
protein
potenti
protect
implic
first
step
viral
entri
process
bind
ntermin
portion
viral
protein
unit
pocket
receptor
second
step
believ
utmost
import
viral
entri
protein
cleavag
unit
oper
receptor
transmembran
proteas
serin
member
hepsintmprss
subfamili
stechiometr
contigu
receptor
cleavag
viral
protein
crucial
step
detach
remain
viral
undergo
conform
rearrang
drive
complet
fusion
viral
cellular
membran
subsequ
entri
viru
cell
releas
content
replic
infect
cell
import
support
evid
entri
sarscov
cell
partial
block
camostat
mesyl
inhibitor
site
receptor
gene
map
x
chromosom
express
seem
higher
asian
white
africanamerican
peopl
receptor
ubiquit
particular
receptor
express
heart
endothelium
coronari
arteri
myocit
fibroblast
epicardi
adipocit
vessel
vascular
endotheli
smooth
cell
gut
intestin
epitheli
cell
lung
tracheal
bronchial
epitheli
cell
type
pneumocyt
macrophag
kidney
lumin
surfac
tubular
epitheli
cell
testi
brain
lung
wide
surfac
alveolar
epitheli
cell
might
explain
vulner
organ
consequ
viru
invas
mostli
bound
cell
membran
scarc
present
circul
solubl
form
disintegrin
metalloproteinas
upregul
angiotensin
ii
type
receptor
receptor
cleav
membraneanchor
therebi
releas
circul
activ
form
loss
catalyt
activ
remain
part
enzym
anchor
membran
elev
circul
level
solubl
marker
differ
diseas
state
character
increas
activ
reninangiotensin
system
associ
wors
prognosi
angel
devil
current
pandem
receptor
consid
devil
entri
door
viru
evid
phenomenon
strong
convinc
hoffmann
et
al
wall
et
al
provid
unequivoc
evid
gain
access
cell
receptor
happen
sarscov
evid
complet
pictur
exampl
mous
model
sarscov
infect
viru
entri
enhanc
overexpress
antibodi
antiac
antibodi
abl
block
sarscov
viral
invas
also
block
n
aziridineethamin
specif
inhibitor
pulmonari
lesion
induc
experiment
sarscov
infect
less
aggress
mice
wildtyp
mice
time
howev
receptor
exert
salutari
biolog
function
turn
angel
sever
aspect
pivot
protect
function
degrad
angiotensin
ii
although
abl
metabol
biolog
peptid
includ
bradykinin
degrad
angiotensin
ii
angiotensin
block
select
inhibitor
like
understand
relev
angiotensin
ii
degrad
result
import
review
biolog
effect
angiotensin
ii
angiotensin
ii
serv
potent
vasoconstrictor
stimul
aldosteron
releas
differ
experiment
clinic
model
angiotensin
ii
trigger
varieti
import
advers
reaction
includ
myocardi
hypertrophi
dysfunct
interstiti
fibrosi
endotheli
dysfunct
enhanc
inflamm
obesityassoci
hypertens
oxid
stress
increas
coagul
detail
discuss
mechan
angiotensin
ii
mediat
reaction
purpos
review
current
pandem
infect
associ
pulmonari
inflamm
acut
respiratori
distress
syndrom
ard
interest
note
angiotensin
ii
also
interfer
adapt
immun
activ
machrophag
cell
immun
system
consequ
increas
product
inflammatori
citokyn
import
remark
deleteri
effect
angiotensin
ii
summar
almost
entir
result
stimul
receptor
chain
event
defin
receptor
axi
receptor
reduc
advers
effect
angiotensin
ii
degrad
angiotensin
ii
therebi
elimin
limit
deleteri
potenti
also
gener
angiotensin
angiotensin
exert
numer
salutari
opposit
counterregulatori
effect
angiotensin
ii
effici
bind
g
proteincoupl
receptor
ma
angiotensin
ii
type
receptor
receptor
therefor
receptor
axi
counterregulatori
receptor
axi
santo
et
al
provid
excel
review
multipl
effect
receptor
axi
receptor
axi
lung
studi
address
pulmonari
effect
angiotensin
appear
particularli
appeal
ma
receptor
express
surfac
bronchial
smooth
muscl
cell
alveolar
epithelium
experiment
clinic
model
lung
inflamm
angiotensin
exert
antiinflammatori
effect
less
infiltr
lymphocyt
neutrophil
reduc
perivascular
peribronchi
inflamm
prevent
subsequ
fibrosi
express
lumin
side
bronchial
ciliat
epithelia
remov
singl
amino
acid
residu
also
polypeptid
desarg
bradykinin
dabk
therebi
prevent
bind
dabk
bradykinin
receptor
receptor
presenc
reduc
function
lung
induc
endotoxin
increas
free
dabk
turn
activ
receptor
releas
proinflammatori
cytokin
intens
lung
inflammatori
injuri
receptor
axi
thrombosi
receptor
axi
exert
antithrombot
effect
ma
receptor
express
platelet
stimul
ma
receptor
angiotensin
increas
prostacyclin
releas
anim
knockout
ma
receptor
shorter
bleed
time
increas
size
thrombi
anim
administr
angiotensin
induc
mark
antithrombot
effect
directli
relat
plasma
level
angiotensin
inhibit
antagonist
ma
receptor
thu
angiotensin
play
import
role
oppos
prothrombot
proinflammatori
effect
angiotensin
ii
receptor
axi
endocrin
system
receptor
axi
well
express
pancrea
improv
insulin
secret
possibl
improv
periinsular
blood
flow
inhibit
fibrosi
result
increas
releas
receptor
also
express
adipos
tissu
reduct
note
adipos
tissu
obes
anim
anim
experi
diet
rich
fat
decreas
activ
angiotensin
increas
angiotensin
ii
blood
pressur
level
male
femal
anim
reaction
inhibit
blockad
losartan
ovariectomi
femal
anim
show
similar
reaction
male
data
suggest
defici
may
favor
obesityinduc
hypertens
also
express
cardiac
adipocyt
obes
patient
heart
failur
increas
amount
epicardi
adipos
tissu
suggest
defici
induc
heart
failur
preserv
eject
fraction
anim
phenomenon
attribut
adipos
tissu
inflamm
local
activ
macrophag
possess
receptor
cellular
membran
happen
sarscov
bind
sarscov
bind
receptor
subsequ
membran
fusion
viru
entri
cell
lead
downregul
receptor
term
viru
appear
entri
cell
along
membran
receptor
function
remov
extern
site
membran
result
receptor
axi
markedli
attenu
amplif
receptor
axi
sinc
pulmonari
inflamm
result
acut
respiratori
distress
syndrom
ard
potenti
deadli
complic
sarscov
studi
address
lung
complic
downregul
outmost
import
studi
use
differ
model
lung
injuri
show
downregul
receptor
trigger
import
inflammatori
lesion
respiratori
tree
alveolar
wall
thicken
edema
infiltr
inflammatori
cell
bleed
appear
mediat
angiotensin
ii
tracheal
instil
cigarett
smoke
particul
matter
aerodynam
diamet
less
induc
acut
lung
injuri
releas
inflammatori
cytokin
increas
express
ace
consist
receptor
axi
overact
reaction
increas
knockout
mice
model
acid
aspir
induc
acut
lung
injuri
lung
inflammatori
lesion
sever
lethal
knockout
anim
anim
inject
recombin
well
receptor
blocker
attenu
degre
lung
injuri
find
strongli
suggest
protect
lung
injuri
induc
acid
aspir
notabl
lung
injuri
induc
isol
spike
viral
protein
sarscov
ligand
bind
absenc
viral
compon
model
merit
investig
impact
downregul
absenc
confound
effect
viral
invas
replic
author
found
even
isol
spike
viral
protein
induc
downregul
receptor
concomit
increas
angiotensin
ii
lung
tissu
precipit
sever
pulmonari
inflammatori
lesion
also
model
receptor
blocker
attenu
pulmonari
lesion
induc
spike
viral
protein
key
point
remark
mainli
express
pneumocyt
type
ii
small
cylindr
cell
repres
pneumocyt
pneumocyt
type
respons
product
alveolar
surfact
time
function
stem
cell
progenitor
pneumocyt
type
pneumocyt
respons
ga
exchang
therefor
damag
pneumocyt
type
ii
due
bind
coronaviru
receptor
devast
least
three
reason
local
unoppos
receptor
axi
overact
reduc
product
alveolar
surfact
injur
pneumocyt
type
ii
lead
reduc
lung
elast
reduc
repair
pneumocyt
type
lead
impair
ga
exchang
fibrosi
clinic
characterist
patient
infect
sarscov
studi
china
itali
shown
hypertens
diabet
histori
cardiovascular
diseas
frequent
comorbid
patient
infect
older
age
male
sex
two
addit
factor
associ
infect
similar
pictur
emerg
year
ago
sarscov
infect
studi
conduct
patient
infect
patient
men
patient
mean
age
year
frequent
comorbid
hypertens
diabet
histori
cardiovascular
diseas
notabl
patient
develop
ard
older
higher
preval
hypertens
vs
diabet
vs
compar
develop
ard
multivari
analysi
factor
associ
progress
ard
syndrom
death
includ
older
age
neutrophilia
hypercoagul
mainli
reflect
higher
ddimer
abnorm
coagul
paramet
enhanc
thrombosi
predict
poor
prognosi
patient
metaanalysi
studi
conduct
china
total
patient
infect
confirm
hypertens
diabet
histori
cardiovascular
diseas
frequent
comorbid
patient
hypertens
histori
cardiovascular
diseas
significantli
preval
among
sever
patient
recent
analysi
infect
patient
itali
mean
age
patient
year
men
preval
patient
hypertens
diabet
previou
cardiovascular
diseas
respect
patient
hypertens
older
without
hypertens
vs
year
compar
patient
die
intens
care
unit
surviv
former
older
higher
preval
hypertens
vs
p
defici
central
role
infect
interest
note
sever
condit
associ
viral
infect
sever
diseas
share
variabl
degre
defici
exampl
express
lung
markedli
decreas
age
greater
extent
men
women
diabet
mellitu
associ
reduc
express
possibl
effect
glycosyl
sever
experiment
clinic
studi
indic
defici
obtain
delet
inhibit
may
caus
factor
hypertens
treatment
solubl
recombin
reduc
blood
pressur
rise
provok
angiotensin
ii
increas
angiotensin
reduc
angiotensin
ii
defici
associ
exacerb
hypertens
cardiac
hypertrophi
induc
angiotensin
ii
maladapt
left
ventricular
remodel
myocardi
infarct
furthermor
defici
enhanc
suscept
heart
failur
heterozygot
loss
believ
suffici
increas
suscept
heart
diseas
given
premis
tempt
specul
figur
defici
may
play
central
role
pathogenesi
infect
downregul
induc
viral
invas
could
especi
detriment
individu
baselin
defici
due
exampl
older
age
diabet
hypertens
prior
heart
diseas
includ
heart
failur
possibl
mild
moder
defici
may
protect
viral
invas
seem
unlik
intrins
high
affin
receptor
contrast
set
defici
downregul
induc
viru
could
amplifi
imbal
receptor
axi
advers
receptor
axi
protect
lung
level
dysregul
would
much
facilit
progress
inflammatori
hypercoagul
process
share
depend
upon
local
angiotensin
ii
hyperact
insuffici
oppos
angiotensin
chain
event
would
deni
concomit
role
mechan
includ
impair
immun
respons
initi
viral
invas
genet
suscept
hyperinflamm
thrombosi
context
administr
solubl
recombin
angiotensin
could
promis
therapeut
approach
requir
urgent
evalu
clinic
trial
two
trial
losartan
addit
treatment
infect
hospit
hospit
patient
announc
support
background
huge
advers
impact
receptor
axi
overact
patient
possibl
ace
inhibitor
angiotensin
ii
receptor
blocker
arb
may
discontinu
even
temporarili
drug
appear
increas
express
receptor
site
viral
entri
human
organ
activ
debat
sever
scientif
societi
variou
expert
area
express
posit
discontinu
drug
justifi
evid
could
danger
hand
sever
experiment
data
discuss
suggest
potenti
util
arb
particularli
limit
lung
inflamm
viral
invas
hope
result
mention
trial
answer
question
suggest
downregul
induc
cell
entri
sarscov
may
particularli
detriment
subject
preexist
defici
degre
defici
associ
varieti
condit
includ
older
age
hypertens
diabet
cardiovascular
diseas
also
character
peopl
like
infect
present
sever
complic
set
enhanc
defici
produc
viral
invas
mark
dysregul
advers
axi
protect
axi
would
contribut
enhanc
progress
inflammatori
thrombot
process
consider
provid
rational
investig
role
therapeut
approach
conceptu
link
receptor
activ
includ
use
solubl
recombin
angiotensin
angiotensin
ii
type
receptor
blocker
current
evalu
